Short-duration therapy with daclatasvir/asunaprevir/beclabuvir fixed-dose combination plus sofosbuvir in patients with chronic hepatitis C genotype 1 (FOURward Study)

被引：0
|
作者：
Sulkowski, Mark S. [1 ]
Flamm, Steven L. [2 ]
Kayali, Zeid [3 ]
Lawitz, Eric [4 ]
Kwo, Paul Y. [5 ]
McPhee, Fiona [6 ]
Torbeyns, Anne [7 ]
Hughes, Eric A. [8 ]
Swenson, Eugene S. [6 ]
Yin, Philip [6 ]
Linaberry, Misti [8 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Inland Empire Liver Fdn, Rialto, CA USA
[4] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA
[5] Indiana Univ, Indianapolis, IN 46204 USA
[6] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[7] Bristol Myers Squibb, Braine Lalleud, Belgium
[8] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
702
引用
收藏
页码：556A / 556A
页数：1
相关论文
共 50 条
  • [41] Compare the Efficacy of Sofosbuvir Plus Ribavirin Verus Sofosbuvir Plus Daclatasvir in Patients with Chronic C Hepatitis Genotype 2 Infection
    Chang, Kuo-Chin
    Hu, Tsung-Hui
    Chen, Chien Hung
    Wang, Jing-Houng
    HEPATOLOGY, 2018, 68 : 586A - 586A
  • [42] Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease
    Kondo, Chisa
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Abe, Hiroshi
    Asano, Toru
    Yoshizawa, Kai
    Okubo, Tomomi
    Chuganji, Yoshimichi
    Aizawa, Yoshio
    Iio, Etsuko
    Tanaka, Yasuhito
    Iwakiri, Katsuhiko
    HEPATOLOGY RESEARCH, 2017, 47 (11) : 1165 - 1173
  • [43] A Pilot Evaluation of Twice Daily Fixed Dose Combination Asunaprevir plus Daclatasvir plus Beclabuvir ± Weight Based Ribavirin in Treatment-Naive, Non-cirrhotic Patients with Chronic Genotype 1a Hepatitis-C for Eight, Six or Four Weeks (RHACE-1)
    Botwin, Gregory J.
    Asghar, Aliya
    Modi, Deval
    Bosman, Dean
    Morgan, Timothy R.
    HEPATOLOGY, 2015, 62 : 570A - 570A
  • [44] Changes of liver fibrosis parameters after daclatasvir plus asunaprevir therapy in genotype 1b chronic hepatitis C Korean patients
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 193 - 194
  • [45] Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study
    Kawakami, Yoshiiku
    Ochi, Hidenori
    Hayes, Clair Nelson
    Imamura, Michio
    Tsuge, Masataka
    Nakahara, Takashi
    Katamura, Yoshio
    Kohno, Hiroshi
    Kohno, Hirotaka
    Tsuji, Keiji
    Takaki, Shintaro
    Mori, Nami
    Honda, Yohji
    Arataki, Keiko
    Takahashi, Shoichi
    Kira, Shinsuke
    Tamura, Toru
    Masuda, Kazunari
    Nakamura, Toshio
    Kikkawa, Masaya
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (04) : 548 - 556
  • [46] Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b-Infected Patients on Hemodialysis
    Miyazaki, Ryoichi
    Miyagi, Kyoko
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (05) : 462 - 467
  • [47] Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study
    Yoshiiku Kawakami
    Hidenori Ochi
    Clair Nelson Hayes
    Michio Imamura
    Masataka Tsuge
    Takashi Nakahara
    Yoshio Katamura
    Hiroshi Kohno
    Hirotaka Kohno
    Keiji Tsuji
    Shintaro Takaki
    Nami Mori
    Yohji Honda
    Keiko Arataki
    Shoichi Takahashi
    Shinsuke Kira
    Toru Tamura
    Kazunari Masuda
    Toshio Nakamura
    Masaya Kikkawa
    Kazuaki Chayama
    Journal of Gastroenterology, 2018, 53 : 548 - 556
  • [48] DACLATASVIR, ASUNAPREVIR, AND BMS-791325 IN A FIXED-DOSE COMBINATION: A PHASE 1 BIOAVAILABILITY STUDY IN HEALTHY VOLUNTEERS
    Adamczyk, R.
    Sims, K.
    Chang, I.
    Filoramo, D.
    Pursley, J.
    Charlton, S.
    Koo, O.
    Bertz, R.
    Rege, B.
    AbuTarif, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S468 - S469
  • [49] Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection
    Stedman, C. A. M.
    Hyland, R. H.
    Ding, X.
    Pang, P. S.
    Mchutchison, J. G.
    Gane, E. J.
    HAEMOPHILIA, 2016, 22 (02) : 214 - 217
  • [50] Sofosbuvir/ledipasvir fixed-dose combination for treatment of chronic hepatitis C virus infection in children
    Rizza, S. A.
    Nehra, V.
    Temesgen, Z.
    DRUGS OF TODAY, 2017, 53 (08) : 447 - 451
12345